Allstate Corp Sarepta Therapeutics, Inc. Transaction History

Allstate Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $186,766 - $436,735	-2,585 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$125.56 - $178.74 $14,816 - $21,091	118 Added 4.78%	2,585 $441,000
Q2 2020 Aug 13, 2020	SELL	$93.0 - $171.7 $72,633 - $134,097	-781 Reduced 24.05%	2,467 $396,000
Q1 2020 May 15, 2020	BUY	$82.38 - $131.64 $110,553 - $176,660	1,342 Added 70.41%	3,248 $318,000
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $145,866 - $258,415	1,906 New	1,906 $246,000
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $507,048 - $1.09 Million	-6,964 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$112.21 - $151.95 $781,430 - $1.06 Million	6,964 New	6,964 $1.06 Million

534

85.3M

1.55M

1.35M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $6.38B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

Stay updated on Allstate Corp with notifications on news.